Investigation in Progress — No Complaint Filed Yet

BG&G is actively investigating potential securities fraud claims against Dynex Capital, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.

Why Is Dynex Capital, Inc. (DX) Under Investigation?

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Dynex Capital, Inc. (NYSE: DX).

On October 19, 2026, Dynex reported its third-quarter 2026 financial results, disclosing a book value per common share of $10.91 as of September 30, 2026, a decrease of $1.99 per share, or 15.4%, from the prior quarter. The Company attributed the decline to late-quarter volatility and widening mortgage spreads. Following this news, Dynex’s stock price dropped $0.37 per share, or approximately 3.39%, to close at $10.56 per share on October 19, 2026.

What Potential Securities Violations Is BG&G Investigating?

  • Whether Dynex Capital, Inc. and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
  • Whether Dynex Capital, Inc. failed to disclose material adverse information that would have been significant to a reasonable investor.
  • Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.

What Should Dynex Capital, Inc. (DX) Investors Do?

If you purchased or acquired DX securities and suffered a loss, you may have a claim.
Contact BG&G to share relevant facts or information about your purchase.
There is no cost or obligation — our firm works exclusively on a contingency fee basis.
You do not need to have sold your shares to contact us.

How Did Dynex Capital, Inc. (DX) Stock React?

How Does BG&G Help Investors in Securities Fraud Investigations?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.

“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”
— Peretz Bronstein, Founding Partner